Received Jul 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | Y019158 | OT |
no adverse event; Caller reported CAPVAXIVE administered during temperature excursion. No other information provided. No additional AE/PQC reported. ? Names of vaccines involved (including lot/exp) CAPVAXIVE Y019158 5/20/2026 ? Temperature 18C; This spontaneous report was received from an other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started was vaccinated with an improperly stored dose of Pneumococcal 21-valent Conjugate Vaccine Injection (CAPVAXIVE) (route of administration and anatomical location of vaccine); lot #Y019158, expiration date reported as 20-MAY-2026 0.5 mL for Prophylaxis. On 25-JUN-2025, the dose experienced a Temperature excursion of 18C for a time fram of 5 hours and 30 minutes. No previous excursion was reported. No additional adverse event were reported.